Pink October begins with genetic awareness
October is a global event to raise awareness about breast cancer and encourage women to take care of their health and learn about the importance of early detection and appropriate medical examinations. With the continuous development in genetic medicine, awareness is no longer limited to knowing the symptoms, but now includes understanding the genetic factors that may affect the likelihood of developing cancer.
This is where the role comes in Enigma Genomics In raising awareness of the importance of genetic information and helping individuals understand the role of genetic testing in assessing health risks and making more informed medical decisions.
What is Pink October and why is breast cancer awareness becoming increasingly important?
Pink October is Breast Cancer Awareness Month, an opportunity to encourage women to get screened and recognize signs that warrant a doctor's visit. Breast cancer is one of the most common cancers among women worldwide, and early detection can offer better treatment options depending on the specific case and stage of the disease.
Awareness campaigns emphasize the importance of knowing the family's health history, paying attention to any new changes in the breast, and adhering to doctors' recommendations regarding imaging and regular checkups.
And it seeks Enigma Genomics To promote the concept of genetic awareness as an important part of modern health education, especially among people with a family history of certain types of cancer.
What is the relationship between genes and breast cancer?
Body cells contain DNA, which carries the genetic instructions responsible for regulating many vital functions, including cell growth and repairing damage that may affect their genetic material.
In some cases, a person inherits a gene mutation that may increase their likelihood of developing certain types of cancer. These cases are known as a genetic predisposition to cancer. However, having a gene mutation associated with increased risk does not mean that developing the disease is a certainty.
Among the most well-known genes associated with hereditary breast cancer are BRCA1 and BRCA2, along with other genes such as PALB2, CHEK2, and TP53. Certain harmful changes in these genes may be linked to an increased risk of breast cancer or other types of cancer.
And help Enigma Genomics Raising awareness among individuals about the importance of understanding genetic risks, along with the necessity of consulting specialists to determine the appropriate test and interpret the results in light of personal, family, and health history.
What is the difference between hereditary breast cancer and non-hereditary breast cancer?
Not every breast cancer diagnosis is evidence of a genetic cause; most cancers result from a combination of factors and may occur without a clear family history.
Hereditary breast cancer, in some cases, is linked to inherited genetic changes passed from one parent to the child, which may lead to an increased likelihood of developing the disease.
Some indicators that may warrant specialized genetic evaluation include:
Having multiple family members with breast cancer
Diagnosis of a relative with breast cancer at a young age
Having a family history of ovarian cancer or certain other cancers associated with genetic syndromes
Having a known harmful gene mutation in a family member
Family history of breast cancer in men
And help Enigma Genomics In promoting awareness of the importance of genetic testing within healthcare, while emphasizing that the decision to conduct testing is based on medical evaluation and not solely on the presence of a single case in the family.
What is the importance of testing for BRCA1 and BRCA2 genes?
The BRCA1 and BRCA2 genes play an important role in repairing DNA damage and maintaining cell integrity, and certain harmful inherited variations in these genes may increase the risk of breast and ovarian cancer and may also be linked to other types of cancer.
Genetic testing, when medically motivated, can help identify specific genetic variations associated with increased risk. The results, along with health and family information, are used to determine follow-up needs and discuss appropriate preventive options with a physician.
It is important to distinguish between genetic predisposition testing and cancer diagnostic tests. Genetic testing does not necessarily reveal the presence of a current tumor and does not replace mammograms or other diagnostic tests.
And encourage Enigma Genomics To disseminate accurate knowledge about the role of genes so that individuals can discuss their medical options based on clear information rather than relying on guesswork or unreliable information.
How do genetic tests help in assessing cancer risk?
Genetic testing looks for specific changes in genetic material, and some of these tests may help identify a genetic predisposition to developing different types of cancer.
Tests vary in the number of genes they cover, the types of changes they can detect, and their medical purpose; therefore, it is important to choose the appropriate test according to your health and family history and medical recommendations.
The test results may contribute to
Identifying some inherited genetic changes associated with an increased risk of cancer
Helping the doctor assess the need for more personalized medical follow-up
Supporting discussion of appropriate preventive options for certain individuals
Providing information that may help guide some treatment decisions for cancer patients
Clarify whether it is appropriate for other family members to undergo genetic evaluation.
In this context, it works Enigma Genomics Genetic testing services are offered to help understand certain genetic risks, but it is important that the results be interpreted by specialists and not considered a definitive prediction of disease occurrence.
Discover the MyCancerCare test from Enigma Genomics
Among the options available for understanding genetic cancer risk, Enigma Genomics offers MyCancerCare, a comprehensive genetic cancer screening test that aims to assess the likelihood of developing various types of cancer by analyzing genes associated with genetic predisposition, according to the approved screening criteria.
Screening can help provide information to support medical discussions about genetic risks, follow-up options, and prevention. The results may also be useful in guiding some treatment decisions for people with cancer, depending on the individual case and medical assessment.
And it offers Enigma Genomics This option is for people who wish to learn about the genetic tests available to understand the risks of hereditary cancer, with the importance of determining the suitability of the test for each individual case through medical consultation.
What should you know before getting MyCancerCare?
Before undergoing any genetic testing, it is advisable to discuss your personal, family, and medical history with the specialist, and to understand the types of genes covered by the test, its limitations, and how to interpret the results.
It should also be noted that a negative result does not rule out all genetic risks, and the presence of a gene mutation does not necessarily mean that the person will develop cancer. The significance of the result depends on the type of gene mutation and the individual's medical context.
You can find details about the examination on the page Enigma Genomics Designed for the MyCancerCare package
Does genetic testing replace mammograms?
The answer is no; genetic testing and mammography perform two different functions.
Genetic testing helps assess certain risks associated with genetic changes, while mammography is used to detect changes in breast tissue, including some tumors that may not be palpable.
Therefore, routine checkups should not be postponed or dispensed with because of a reassuring genetic result, nor should a genetic test result associated with high risk be considered a definitive diagnosis of cancer.
And she explains Enigma Genomics The importance of understanding the role of genetic testing within the healthcare system so that genetic information is integrated with appropriate medical follow-up.
What are the signs that warrant a doctor's visit?
Paying attention to new changes in the breast helps in seeking medical evaluation when needed, and these are some signs that warrant a check-up.
Appearance of a new lump in the breast or armpit area
A noticeable change in breast size or shape
Skin shrinkage or unusual changes in its texture
A new change in the nipple or its inversion
Unusual nipple discharge, especially if it is bloody
These symptoms do not necessarily mean breast cancer; they may have other causes. However, it is important not to ignore them and to consult a doctor to determine the appropriate tests.
And confirms Enigma Genomics Health awareness combines knowledge of risk factors, attention to symptoms, and adherence to recommended medical guidelines.
How can a family benefit from knowing about genetic risks?
The importance of discovering an inherited genetic change may not be limited to the person who underwent the test; the information can also be important for family members. If a harmful genetic change associated with an increased risk of cancer is identified, the specialist may recommend evaluating certain relatives based on the type of change, degree of kinship, and medical history.
Genetic assessment helps to understand risks more accurately, but it requires respecting privacy, providing appropriate advice, and avoiding conclusions not supported by medical findings.
And it supports Enigma Genomics The concept of genetic awareness helps individuals and families understand genetic information and use it to make informed health decisions.
Pink October begins with a step towards knowledge
Breast cancer awareness is not limited to October; it is an ongoing responsibility that requires attention to health, understanding risk factors, discussing family history, and committing to appropriate screenings.
Advances in the field of genetic medicine offer better opportunities to understand some genetic risks, but they do not negate the importance of early detection, clinical screening, or specialized medical evaluation.
By raising awareness about genetic testing options, we contribute Enigma Genomics In spreading knowledge about the role of genes in health and encouraging individuals to take steps based on scientific information
If you would like to understand the genetic risks associated with cancer, you can review the details of the MyCancerCare screening and discuss its suitability with specialists.
Start with awareness, ask about the options that are right for you, and make your health a priority this Pink October and throughout the year.